22-20425532-G-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_182895.5(SCARF2):āc.2444C>Gā(p.Ala815Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.346 in 1,341,348 control chromosomes in the GnomAD database, including 83,597 homozygotes. In-silico tool predicts a benign outcome for this variant. 10/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_182895.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCARF2 | NM_182895.5 | c.2444C>G | p.Ala815Gly | missense_variant | 11/11 | ENST00000622235.5 | NP_878315.2 | |
SCARF2 | NM_153334.7 | c.2459C>G | p.Ala820Gly | missense_variant | 11/11 | NP_699165.3 | ||
SCARF2 | XM_047441585.1 | c.2558C>G | p.Ala853Gly | missense_variant | 11/11 | XP_047297541.1 | ||
SCARF2 | XM_017029065.3 | c.*673C>G | 3_prime_UTR_variant | 11/11 | XP_016884554.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.332 AC: 50301AN: 151642Hom.: 8755 Cov.: 32
GnomAD3 exomes AF: 0.301 AC: 7826AN: 25994Hom.: 1184 AF XY: 0.309 AC XY: 4775AN XY: 15464
GnomAD4 exome AF: 0.348 AC: 414113AN: 1189596Hom.: 74844 Cov.: 39 AF XY: 0.345 AC XY: 198299AN XY: 575466
GnomAD4 genome AF: 0.332 AC: 50313AN: 151752Hom.: 8753 Cov.: 32 AF XY: 0.330 AC XY: 24467AN XY: 74182
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 05, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Van den Ende-Gupta syndrome Benign:2
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | Jan 15, 2016 | - - |
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
not specified Benign:1
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at